Gwenn Hansen sold $36K of NRIX stock

Gwenn Hansen, Chief Scientific Officer of Nurix Therapeutics, Inc. (NRIX), sold 1,452 shares of NRIX stock worth $36K, per an SEC Form 4 filed Oct 15, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Oct 15, 2026.

NRIX has moved -38.7% since the trade date, from $24.95 to $15.30 (Nov 6, 2026 close).